drugset / Trial / NCT03143192

Treatment of Diabetic Macular Edema With Aflibercept and Micropulse Laser

NCT03143192

Phase 2/3 Completed 31 enrolled Keyvan Koushan
RandomizedParallel-groupDouble-blindTreatment

Summary

The goal of this pilot study is to investigate the safety and efficacy of micropulse (MP) macular laser in combination with intravitreal aflibercept for the treatment of centre-involved diabetic macular edema.

Timeline

Start
2017-03-08
Primary completion
2019-05-09
Completion
2019-05-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Aflibercept Protein / enzyme biologic 2 mg Intravitreal